Key Takeaways
- Shares of IBM plunged more than 4% during premarket trading Thursday following Accenture’s decision to lower its fiscal 2026 revenue outlook
- Accenture revised its annual revenue forecast to $71.76B–$72.46B, reducing the previous upper target of $73.16B
- While Accenture’s Q3 earnings per share of $3.80 exceeded projections, third-quarter revenue of $18.7B fell short of the $18.745B analyst estimate
- According to GF Value analysis, IBM is approximately 9.9% overvalued at $262.35, carrying a GF Score of 78 out of 100
- IBM is scheduled to release Q2 financial results on July 22, with Wall Street forecasting EPS of $3.00 and revenue of $17.85B
Shares of International Business Machines took a notable hit Thursday morning after rival Accenture trimmed its revenue projections for fiscal 2026, creating a ripple effect throughout the IT services industry.
International Business Machines Corporation, IBM
During premarket hours, IBM shares were changing hands at $251.01, representing a 4.32% decline. This follows a 3.1% drop to $262.35 at Tuesday’s closing bell on June 17.
The pressure on IBM wasn’t the result of any company-specific news. Instead, it was Accenture’s revised financial outlook that rattled investor confidence.
Accenture adjusted its full-year revenue projection to a band between $71.763 billion and $72.460 billion. This represents a reduction from the prior high-end estimate of $73.157 billion. Analysts had been anticipating approximately $74.006 billion for the fiscal year.
This type of guidance adjustment typically creates a domino effect throughout the sector — and IBM became one of its casualties.
Despite the revenue miss, Accenture delivered positive news on profitability. The company’s Q3 diluted earnings per share reached $3.80, surpassing the $3.69 Wall Street forecast. However, third-quarter revenue of $18.700 billion slightly underperformed the $18.745 billion consensus expectation, and the forward-looking revision weighed heavily on sentiment.
Accenture’s CEO Julie Sweet highlighted robust demand for artificial intelligence services, revealing 104 client agreements valued at $100 million or greater during the year-to-date period, representing a 13% increase. Additionally, the company unveiled plans to purchase a controlling interest in Dragos, alongside complete acquisitions of runZero and NetRise, focusing on the operational technology cybersecurity space.
IBM Prepares to Unveil Q2 Results on July 22
IBM’s quarterly financial disclosure is set for July 22. Wall Street consensus calls for earnings per share of $3.00 alongside revenue of $17.85 billion for the second quarter.
During the first quarter, IBM delivered EPS of $1.91, exceeding the $1.81 analyst forecast. Revenue totaled $15.92 billion, topping the $15.66 billion projection. This performance extended the company’s streak of surpassing earnings estimates to eight straight quarters — a track record investors will monitor closely for continuation.
Examining IBM’s Current Valuation Metrics
According to GuruFocus analysis, IBM’s GF Value stands at $238.63, indicating the stock was trading at approximately a 9.9% premium above this fair value benchmark at $262.35.
IBM’s present price-to-earnings ratio of 23.2x falls marginally below its five-year median of 24.4x. The forward-looking P/E ratio registers at 21.1x.
The company’s GF Score of 78 out of 100 signals above-average standing compared to industry competitors, with profitability representing the strongest element at 8 out of 10. Financial strength registers at 5 out of 10, while momentum scores 4 out of 10 — the latter aligning with Thursday’s downward movement.
An additional observation: insider trading activity has been absent over the previous three-month period.
IBM’s 52-week trading range extends from $212.34 to $332.46, positioning Thursday’s premarket level of $251.01 toward the lower portion of this spectrum.
The upcoming major event for IBM investors arrives July 22.





